07:45 AM EDT, 08/21/2025 (MT Newswires) -- Tharimmune ( THAR ) shares were nearly 35% higher pre-bell Thursday, extending Wednesday's rally.

Evoke Pharma ( EVOK ) stock was up 30% after the company said its US patent for its gastroparesis nasal spray has been listed in the US Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations.

Cato (CATO) shares were up 14% after the company reported higher fiscal Q2 earnings and revenue year over year.

Fundamental Global ( FGNX ) stock was up 9.2%, following a 0.1% gain in the previous session.